Literature DB >> 16019133

NCOR1 mRNA is an independent prognostic factor for breast cancer.

Zhenhuan Zhang1, Hiroko Yamashita, Tatsuya Toyama, Hiroshi Sugiura, Yoshiaki Ando, Keiko Mita, Maho Hamaguchi, Yasuo Hara, Shunzo Kobayashi, Hirotaka Iwase.   

Abstract

The transcriptional function of estrogen receptor alpha (ERalpha) can be modulated by co-regulatory proteins. In the present study, therefore, the level of expression of one of the co-regulator Nuclear Receptor Co-repressor 1 (NCOR1) mRNA has been assessed by quantitative real-time RT-PCR in 160 cases of invasive breast carcinoma. It was found that NCOR1 mRNA was expressed at significantly higher levels in patients over 50 years of age, without axillary lymph node involvement, with tumor size less than 2 cm, with low or intermediate histological grade, with ERalpha/PgR-positive and with HER2 negative tumors. Patients with high levels of expression of NCOR1 mRNA have a better prognosis than those with low expression. Univariate and multivariate prognostic analysis demonstrated that NCOR1 mRNA is an independent prognostic factor for breast cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019133     DOI: 10.1016/j.canlet.2005.05.046

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

Review 1.  Nuclear Receptor Coregulators in Hormone-Dependent Cancers.

Authors:  Hedieh Jafari; Shahid Hussain; Moray J Campbell
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

2.  Pan-cancer analyses of the nuclear receptor superfamily.

Authors:  Mark D Long; Moray J Campbell
Journal:  Nucl Receptor Res       Date:  2015-12-15

Review 3.  Transcription factor co-repressors in cancer biology: roles and targeting.

Authors:  Sebastiano Battaglia; Orla Maguire; Moray J Campbell
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

Review 4.  Minireview: nuclear receptors and breast cancer.

Authors:  Suzanne D Conzen
Journal:  Mol Endocrinol       Date:  2008-04-16

5.  Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.

Authors:  Craig L Doig; Prashant K Singh; Vineet K Dhiman; James L Thorne; Sebastiano Battaglia; Michelle Sobolewski; Orla Maguire; Laura P O'Neill; Bryan M Turner; Christopher J McCabe; Dominic J Smiraglia; Moray J Campbell
Journal:  Carcinogenesis       Date:  2012-10-20       Impact factor: 4.944

6.  Luteolin Regulation of Estrogen Signaling and Cell Cycle Pathway Genes in MCF-7 Human Breast Cancer Cells.

Authors:  Barry M Markaverich; Kevin Shoulars; Mary Ann Rodriguez
Journal:  Int J Biomed Sci       Date:  2011

7.  Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity.

Authors:  Mark D Long; Patrick R van den Berg; James L Russell; Prashant K Singh; Sebastiano Battaglia; Moray J Campbell
Journal:  Nucleic Acids Res       Date:  2015-06-27       Impact factor: 16.971

8.  Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.

Authors:  Laura Fozzatti; Jeong Won Park; Li Zhao; Mark C Willingham; Sheue-Yann Cheng
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

9.  Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer.

Authors:  Roisin E McNeill; Nicola Miller; Michael J Kerin
Journal:  BMC Mol Biol       Date:  2007-11-27       Impact factor: 2.946

Review 10.  Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.

Authors:  Prashant K Singh; Craig L Doig; Vineet K Dhiman; Bryan M Turner; Dominic J Smiraglia; Moray J Campbell
Journal:  J Steroid Biochem Mol Biol       Date:  2012-10-23       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.